Skip to content

Ethos Technologies, Inc. LIFE Proceeds From Issuance Of Common Stock Through At Market Offering Net Of Offering Costs

Proceeds From Issuance Of Common Stock Through At Market Offering Net Of Offering Costs at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$137.09M
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$12.11M
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$16.4M+50.7%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$9.75M
Enliven Therapeutics logo
Enliven TherapeuticsELVN
$0-100%
UMH
UMH PropertiesUMH
$0-100%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+24.1%
Enterprise value$1.14B
P/S6,001×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by Ethos Technologies, Inc. in its filing.

Tagged under the XBRL concept atyr:ProceedsFromIssuanceOfCommonStockThroughAtMarketOfferingNetOfOfferingCosts.

The official record: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ethos Technologies, Inc. 's proceeds from issuance of common stock through at market offering net of offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ethos Technologies, Inc. 's proceeds from issuance of common stock through at market offering net of offering costs?
Ethos Technologies, Inc. (LIFE) reported proceeds from issuance of common stock through at market offering net of offering costs of $0 in Q1 2026.
How has Ethos Technologies, Inc. 's proceeds from issuance of common stock through at market offering net of offering costs changed year-over-year?
Ethos Technologies, Inc. 's proceeds from issuance of common stock through at market offering net of offering costs decreased by 100.0% year-over-year, from $18.76M to $0.
What is the long-term trend for Ethos Technologies, Inc. 's proceeds from issuance of common stock through at market offering net of offering costs?
Over 2 years (2022 to 2025), Ethos Technologies, Inc. 's proceeds from issuance of common stock through at market offering net of offering costs has grown at a 248.5% compound annual growth rate (CAGR), from $5.47M to $66.44M.
What does proceeds from issuance of common stock through at market offering net of offering costs mean?
This represents the net cash proceeds received from selling common stock into the public market at prevailing market prices, typically through an at-the-market (ATM) offering program. It is a flexible financing mechanism used by companies to raise capital incrementally without the need for a traditional underwritten offering. This metric is critical for assessing the company's ability to access liquidity and the potential dilution to existing shareholders.